Holen Sie sich die Stockscreener-App
74.36
7.02%
4.88
Handel nachbörslich:
74.37
0.01
+0.01%
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green - Yahoo Finance
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 17, 2025 - BioSpace
(WGS) Technical Data - Stock Traders Daily
Assenagon Asset Management S.A. Sells 61,642 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx (NASDAQ:WGS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
GeneDx (NASDAQ:WGS) Trading Down 7.2%Here's What Happened - MarketBeat
Barclays PLC Acquires 14,681 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings: A Phenomenal Comeback With More Room To Run - Seeking Alpha
GeneDx raises Q4 adjusted gross margin view to 68% from 64% - Yahoo Finance
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains? - MSN
GeneDx anticipates higher-than-expected annual revenues - MSN
GeneDx Holdings Expects Strong 2024 Financial Performance - TipRanks
GeneDx forecasts strong revenue and gross margin growth By Investing.com - Investing.com South Africa
Why Have GeneDx Holdings Stocks Plummeted? - TipRanks
GeneDx forecasts strong revenue and gross margin growth - Investing.com India
GeneDx Announces Preliminary 2024 Financial Results - Business Wire
Insider Sell: Katherine Stueland Sells 51,420 Shares of GeneDx H - GuruFocus.com
Genedx CEO sells shares worth $4.86 million - Investing.com India
Genedx CEO sells shares worth $4.86 million By Investing.com - Investing.com Australia
GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $3,331,172.92 in Stock - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 51,420 Shares - MarketBeat
GeneDx (NASDAQ:WGS) Stock Price Down 6.3%What's Next? - MarketBeat
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers - Business Wire
How the (WGS) price action is used to our Advantage - Stock Traders Daily
TD Cowen Boosts GeneDx (NASDAQ:WGS) Price Target to $118.00 - Defense World
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Looks Just Right With A 26% Price Jump - Simply Wall St
TD Cowen Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - MarketBeat
Genedx CEO Katherine Stueland sells shares worth $1.4 million By Investing.com - Investing.com Australia
GeneDx (NASDAQ:WGS) Hits New 52-Week HighShould You Buy? - MarketBeat
2025 investment picks - substack.com
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 18,006 Shares - MarketBeat
Kevin Feeley Sells 1,430 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
Genedx CFO Kevin Feeley sells $108,736 in stock By Investing.com - Investing.com Australia
Genedx CFO Kevin Feeley sells $108,736 in stock - Investing.com India
Genedx CEO Katherine Stueland sells shares worth $1.4 million - Investing.com
GeneDx (NASDAQ:WGS) Stock Price Up 7.3%Time to Buy? - MarketBeat
When Will GeneDx Holdings Corp. (NASDAQ:WGS) Turn A Profit? - Simply Wall St
Principal Financial Group Inc. Acquires New Stake in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Principal Financial Group Inc. Invests $604,000 in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
5 Stocks To Watch Heading Into Friday - MSN
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday - Benzinga
GeneDx Holdings Appoints Bryan Dechairo as COO - TipRanks
1.52%
2.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):